GlycoMimetics Inc (GLYC) concluded trading on Thursday at a closing price of $0.42, with 3.84 million shares of worth about $1.61 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 40.97% during that period and on November 07, 2024 the price saw a gain of about 11.58%. Currently the company’s common shares owned by public are about 64.39M shares, out of which, 59.08M shares are available for trading.
Stock saw a price change of 3.24% in past 5 days and over the past one month there was a price change of 192.75%. Year-to-date (YTD), GLYC shares are showing a performance of -82.20% which decreased to -68.65% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.14 but also hit the highest price of $3.53 during that period. The average intraday trading volume for GlycoMimetics Inc shares is 19.21 million. The stock is currently trading 59.28% above its 20-day simple moving average (SMA20), while that difference is up 106.89% for SMA50 and it goes to -61.73% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GlycoMimetics Inc (NASDAQ: GLYC) currently have 64.39M outstanding shares and institutions hold larger chunk of about 34.67% of that.
The stock has a current market capitalization of $27.09M and its 3Y-monthly beta is at 1.81. It has posted earnings per share of -$0.61 in the same period. It has Quick Ratio of 5.48 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GLYC, volatility over the week remained 16.59% while standing at 17.33% over the month.
Coverage by CapitalOne stated GlycoMimetics Inc (GLYC) stock as an Overweight in their note to investors on December 22, 2023, suggesting a price target of $12 for the stock. On November 12, 2021, Jefferies Upgrade their recommendations, while on November 14, 2019, ROTH Capital Initiated their ratings for the stock with a price target of $12. Stock get a Hold rating from SunTrust on August 05, 2019.
